Amanda C retweeted
$KEEL small pop
Amanda C retweeted
$ATAI holding well
$ATAI
Canaccord raised the firm's price target on AtaiBeckley to $17 from $15 and keeps a Buy rating on the shares. The firm updated its model after the company announced it has dosed the last patient in its Elumina Phase 2 trial for VLS-01 (DMT buccal film) for treatment-resistant depression (TRD), and reiterated its timeline for top-line data in 4Q26. Based on the data, the company now expects to advance VLS-01 into Phase 3 trials for major depressive disorder (MDD) following which it could expand into generalized anxiety disorder (GAD).
Pay attention to the '' less '' popular ones
@zohmbastic
@Maximus_Holla
@verdetrades
@Sandman7591
@Investaup
@PrintingTendies
@tokenbearer
@bstocks7
The REAL traders with REAL money
$ORTX Coming back to support area under the 5.00 mark
Ill be taking dips in this 4.90-4.50 zone as there is nice catalyst ahead
Its a small float so it have spread and move fast
5.50 > 5.90 > 6.70 > 7.20 are the bigger picture upside level
Yes, he did it again
$TOI .65--.45 added-- .41--The Oncology Institute, Inc.....Bottom Watch.....T/S
$PRSO Peraso Announces $4.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
$MBOT Microbot Medical Announces $1.4 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules
$MBOT Microbot Medical Announces $2.66 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules
$ORTX Orchard Therapeutics Announces Positive Clinical and Preclinical Data in Programs Targeting Neurometabolic and CNS Disorders at ASGCT
$UNCY Starting to form a daily higher low while kissing trendline
1.55 > 1.77 (50MA) which is usually magnet level on breakout
Then 2.00 > 2.15 > 2.25 > 2.50 > 2.90 upside on bigger picture
All dips under 1.30 been getting bought up











